Repurposing of a Nucleoside Scaffold from Adenosine Receptor Agonists to Opioid Receptor Antagonists

被引:12
|
作者
Tosh, Dilip K. [1 ]
Ciancetta, Antonella [1 ]
Mannes, Philip [1 ]
Warnick, Eugene [1 ]
Janowsky, Aaron [2 ,3 ,4 ]
Eshleman, Amy J. [2 ,3 ,4 ]
Gizewski, Elizabeth [5 ]
Brust, Tarsis F. [6 ,7 ]
Bohn, Laura M. [6 ,7 ]
Auchampach, John A. [5 ]
Gao, Zhan-Guo [1 ]
Jacobson, Kenneth A. [1 ]
机构
[1] NIDDK, Mol Recognit Sect, Lab Bioorgan Chem, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA
[2] Oregon Hlth & Sci Univ, VA Portland Hlth Care Syst, Res Serv R&D 22, 3710 SW US Vet Hosp Blvd, Portland, OR 97239 USA
[3] Oregon Hlth & Sci Univ, Dept Psychiat, 3710 SW US Vet Hosp Blvd, Portland, OR 97239 USA
[4] Oregon Hlth & Sci Univ, Dept Behav Neurosci, 3710 SW US Vet Hosp Blvd, Portland, OR 97239 USA
[5] Med Coll Wisconsin, Dept Pharmacol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA
[6] Scripps Res Inst, Dept Mol Med, 130 Scripps Way, Jupiter, FL 33458 USA
[7] Scripps Res Inst, Dept Neurosci, 130 Scripps Way, Jupiter, FL 33458 USA
来源
ACS OMEGA | 2018年 / 3卷 / 10期
关键词
CHRONIC NEUROPATHIC PAIN; 18 KDA TSPO; INDUCED CONSTIPATION; PROTEIN; LIGANDS; BINDING; POTENT; EFFICACY; DESIGN; CANCER;
D O I
10.1021/acsomega.8b01237
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
While screening off-target effects of rigid (N)-methanocarba-adenosine 5'-methylamides as A(3) adenosine receptor (AR) agonists, we discovered mu M binding hits at the d-opioid receptor (DOR) and translocator protein (TSPO). In an effort to increase OR and decrease AR affinity by structure activity analysis of this series, antagonist activity at kappa-(K)OR appeared in 5'-esters (ethyl 24 and propyl 30), which retained TSPO interaction (mu M). 7-Deaza modification of C2-(arylethynyl)-5'-esters but not 4'-truncation enhanced KOR affinity (MRS7299 28 and 29, K-1 approximate to 40 nM), revealed mu-OR and DOR binding, and reduced AR affinity. Molecular docking and dynamics simulations located a putative KOR binding mode consistent with the observed affinities, placing C7 in a hydrophobic region. 3-Deaza modification permitted TSPO but not OR binding, and 1-deaza was permissive to both; ribose-restored analogues were inactive at both. Thus, we have repurposed a known AR nucleoside scaffold for OR antagonism, with a detailed hypothesis for KOR recognition.
引用
收藏
页码:12658 / 12678
页数:21
相关论文
共 50 条
  • [1] Nucleoside prodrugs of A3 adenosine receptor agonists and antagonists
    Besada, Pedro
    Mamedova, Liaman K.
    Palaniappan, Krishnan K.
    Gao, Zhan-Guo
    Joshi, Bhalchandra V.
    Jeong, Lak Shin
    Civan, Mortimer M.
    Jacobson, Kenneth A.
    COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS, 2006, 71 (06) : 912 - 928
  • [2] Transformation of μ-opioid receptor agonists into biologically potent μ-opioid receptor antagonists
    Li, Tingyou
    Jinsmaa, Yunden
    Nedachi, Masahiro
    Miyazaki, Anna
    Tsuda, Yuko
    Ambo, Akihiro
    Sasaki, Yusuke
    Bryant, Sharon D.
    Marczak, Ewa
    Li, Qiang
    Swartzwelder, H. Scott
    Lazarus, Lawrence H.
    Okada, Yoshio
    BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (03) : 1237 - 1251
  • [3] Therapeutic potential of adenosine receptor antagonists and agonists
    Press, Neil J.
    Gessi, Stefania
    Borea, Pier A.
    Polosa, Riccardo
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2007, 17 (08) : 979 - 991
  • [4] FUNCTIONALIZED CONGENERS OF ADENOSINE RECEPTOR AGONISTS AND ANTAGONISTS
    JACOBSON, KA
    DALY, JW
    KIRK, KL
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1985, 189 (APR-): : 38 - MEDI
  • [5] SELECTIVITY OF OPIOID AGONISTS AND ANTAGONISTS FOR THE VARIOUS OPIOID RECEPTOR TYPES
    TAKEMORI, AE
    PORTOGHESE, PS
    PSYCHOPHARMACOLOGY BULLETIN, 1985, 21 (03) : 464 - 465
  • [6] Scaffold Repurposing of Nucleosides (Adenosine Receptor Agonists): Enhanced Activity at the Human Dopamine and Norepinephrine Sodium Symporters
    Tosh, Dilip K.
    Janowsky, Aaron
    Eshleman, Amy J.
    Warnick, Eugene
    Gao, Zhan-Guo
    Chen, Zhoumou
    Gizewski, Elizabeth
    Auchampach, John A.
    Salvemini, Daniela
    Jacobson, Kenneth A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (07) : 3109 - 3123
  • [7] Adenosine receptor agonists attenuate and adenosine receptor antagonists exacerbate opiate withdrawal signs
    Kaplan, GB
    Sears, MT
    PSYCHOPHARMACOLOGY, 1996, 123 (01) : 64 - 70
  • [8] Therapy of bronchial asthma with adenosine receptor agonists or antagonists
    Marx, D
    Ezeamuzie, CI
    Nieber, K
    Szelenyi, I
    DRUG NEWS & PERSPECTIVES, 2001, 14 (02) : 89 - 100
  • [9] Recent advances in selective opioid receptor agonists and antagonists
    Eguchi, M
    MEDICINAL RESEARCH REVIEWS, 2004, 24 (02) : 182 - 212
  • [10] Piperidine propionamide as a scaffold for potent sigma-1 receptor antagonists and mu opioid receptor agonists for treating neuropathic pain
    Xiong, Jiaying
    Jin, Jian
    Gao, Lanchang
    Hao, Chao
    Liu, Xin
    Liu, Bi-Feng
    Chen, Yin
    Zhang, Guisen
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 191